U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056205) titled 'Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.' on June 29.
Brief Summary: Expression of ER, PR and HER2/neu in initial and recurrent breast cancer and correlate the results to different clinical and pathological parameters as patient age,sex, tumor location, status of nodal involvement and lymphovascular invasion
Study Start Date: Jan. 01, 2021
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Sohag University
Information provided by (Responsible Party): Abdelmoaty Nafady Abdelmoaty, Sohag University
Disclaimer: Curated by HT Syndica...